Reduced-size liver transplantation in the mouse

Area of Science:

• Hepatology
• Transplantation immunology
• Surgical innovation

Background:

• Reduced-size liver transplantation (RSLT) is increasingly utilized but carries higher risks of graft damage and failure.
• Understanding the mechanisms of graft injury and regeneration after RSLT is crucial for improving outcomes.

Purpose of the Study:

• To develop and validate a mouse model for studying reduced-size liver transplantation (RSLT).
• To investigate graft injury and regenerative responses following RSLT in a preclinical setting.

Main Methods:

• Developed a 50% reduced-size liver graft model in C57Bl/6 mice, comparing RSLT with full-size transplantation and sham operations.
• Assessed graft injury using alanine transaminase and bilirubin levels, monitored survival, and evaluated regeneration via BrdU incorporation and graft weight.
• Histological analysis was performed to examine graft integrity and cellular response.

Main Results:

• RSLT demonstrated high graft survival rates (100% at 42 hr, 86% at 8 days), comparable to full-size grafts.
• Elevated liver enzymes (ALT, bilirubin) were observed post-RSLT, indicating transient injury, but histology showed minimal damage and signs of regeneration.
• Significant increases in BrdU incorporation (54-fold) and graft weight (67%) post-RSLT confirmed a robust regenerative response.

Conclusions:

• The developed mouse model of 50% RSLT is viable, exhibiting good graft survival and a potent regenerative capacity.
• This model serves as a valuable tool for elucidating the molecular mechanisms of graft injury and regeneration in liver transplantation research.
• Findings support the potential of RSLT with effective regeneration to overcome donor organ shortages.